Your new experience awaits. Try the new design now and help us make it even better

REVIEW article

Front. Oral Health

Sec. Oral Infections and Microbes

Volume 6 - 2025 | doi: 10.3389/froh.2025.1607931

This article is part of the Research TopicUpdates on the Oral Manifestations of Systemic DiseasesView all 3 articles

Membrane Vesicles from Red Complex Bacteria: Key Players in Oral Pathogenesis, Immune Disruption, Systemic Diseases, and Therapeutic Insights

Provisionally accepted
Venkatramanan  MVenkatramanan M1Huldah  Pearlin Sarah LazarusHuldah Pearlin Sarah Lazarus1Gothandam  Kodiveri MuthukaliannanGothandam Kodiveri Muthukaliannan1Sheeja  VargheseSheeja Varghese2Nalini  EaswaranNalini Easwaran1*
  • 1VIT University, Vellore, India
  • 2Saveetha Medical College & Hospital, Chennai, Tamil Nadu, India

The final, formatted version of the article will be published soon.

The oral cavity serves as a habitat for a diverse array of microorganisms, each performing distinct functions, thereby constituting a vibrant and intricate ecological community. The most common pathogenic bacteria in the oral ecosystem are the Red Complex group, which includes Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia. These bacteria have several ways to inflict damage, such as creating biofilms and secreting nano-sized vesicles from their outer membrane, called Outer Membrane Vesicles (OMV). OMVs are nano structures that carry proteins, lipids, and toxins from the outer membrane of gram-negative bacteria. The OMVs of Red Complex bacteria play a role in the onset and development of oral pathological conditions such as gingivitis and periodontitis. Additionally, a substantial body of evidence supports the notion that these OMVs may exert influence on systemic pathologies, including atherosclerosis, alzheimer's, rheumatoid arthritis, and diabetes mellitus. This review will discuss the formation and composition of Red Complex bacterial OMVs, their impacts on the oral environment, the immune response, and their correlations with various systemic diseases. The suggested treatment approach by probiotics and bioactives focuses on the genetic elements that induce the production of OMVs by the Red Complex bacteria, offering a potent means to hinder the advancement of diseases propagated through these OMVs.

Keywords: Red complex bacteria, Outer membrane vesicles (OMVs), Systemic diseases, Probiotics, Phytobioactives

Received: 08 Apr 2025; Accepted: 10 Jul 2025.

Copyright: © 2025 M, Lazarus, Muthukaliannan, Varghese and Easwaran. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Nalini Easwaran, VIT University, Vellore, India

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.